[go: up one dir, main page]

GB9213901D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB9213901D0
GB9213901D0 GB929213901A GB9213901A GB9213901D0 GB 9213901 D0 GB9213901 D0 GB 9213901D0 GB 929213901 A GB929213901 A GB 929213901A GB 9213901 A GB9213901 A GB 9213901A GB 9213901 D0 GB9213901 D0 GB 9213901D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929213901A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Priority to GB929213901A priority Critical patent/GB9213901D0/en
Publication of GB9213901D0 publication Critical patent/GB9213901D0/en
Priority to EP93916878A priority patent/EP0650358A4/en
Priority to JP6502657A priority patent/JPH07508524A/ja
Priority to PCT/US1993/006233 priority patent/WO1994000121A1/fr
Pending legal-status Critical Current

Links

GB929213901A 1992-06-30 1992-06-30 Compounds Pending GB9213901D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB929213901A GB9213901D0 (en) 1992-06-30 1992-06-30 Compounds
EP93916878A EP0650358A4 (en) 1992-06-30 1993-06-30 17-acyl-4-aza-steroid-3-one as 5-alpha-reductase inhibitors.
JP6502657A JPH07508524A (ja) 1992-06-30 1993-06-30 5−アルファ−レダクターゼ阻害剤としての17−アシル−4−アザ−ステロイド−3−オン
PCT/US1993/006233 WO1994000121A1 (fr) 1992-06-30 1993-06-30 17-acyl-4-aza-steroide-3-one a titre d'inhibiteurs de 5-alpha-reductase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929213901A GB9213901D0 (en) 1992-06-30 1992-06-30 Compounds

Publications (1)

Publication Number Publication Date
GB9213901D0 true GB9213901D0 (en) 1992-08-12

Family

ID=10717969

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929213901A Pending GB9213901D0 (en) 1992-06-30 1992-06-30 Compounds

Country Status (4)

Country Link
EP (1) EP0650358A4 (fr)
JP (1) JPH07508524A (fr)
GB (1) GB9213901D0 (fr)
WO (1) WO1994000121A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
US5595996A (en) * 1994-10-25 1997-01-21 Merck & Co., Inc. 7-substituted 4-aza cholanic acid derivatives and their use
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4859681A (en) * 1984-02-27 1989-08-22 Merck & Co., Inc. 17 α-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase inhibitors
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
US5049562A (en) * 1984-02-27 1991-09-17 Merck & Co., Inc. 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α-reductase inhibitors
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
US4888336A (en) * 1987-01-28 1989-12-19 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US5110939A (en) * 1987-01-28 1992-05-05 Smithkline Beecham Corporation Intermediates in the preparation of steriod 5-alpha-reductase inhibitors
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US5116983A (en) * 1988-04-18 1992-05-26 Merck & Co., Inc. Dehydrogenation process intermediates
US4882319A (en) * 1988-12-23 1989-11-21 Smithkline Beckman Corporation Phosphonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase
US5098908A (en) * 1990-06-20 1992-03-24 Merck & Co., Inc. 17β-hydroxybenzoyl-4-aza-5α-androst-1-en-3-ones as testosterone reductase inhibitors
US5300294A (en) * 1990-06-27 1994-04-05 Smithkline Beecham Corporation Method of treating prostatic adenocarcinoma
US5061803A (en) * 1990-09-24 1991-10-29 Merck & Co., Inc. Process for making 17-beta alkanoyl 3-oxo-4-aza-5-α-androst-1-enes

Also Published As

Publication number Publication date
WO1994000121A1 (fr) 1994-01-06
EP0650358A4 (en) 1995-06-07
EP0650358A1 (fr) 1995-05-03
JPH07508524A (ja) 1995-09-21

Similar Documents

Publication Publication Date Title
AP9300508A0 (en) Compounds
GB9209628D0 (en) Compounds
GB9200245D0 (en) Compounds
GB9201694D0 (en) Compounds
GB9200209D0 (en) Compounds
GB9210632D0 (en) Compounds
GB9210880D0 (en) Compounds
GB9200566D0 (en) Compounds
GB9201751D0 (en) Compounds
GB9202792D0 (en) Compounds
GB9201692D0 (en) Compounds
GB9213901D0 (en) Compounds
GB9205859D0 (en) Compounds
GB9210659D0 (en) Compounds
GB9201746D0 (en) Compounds
GB9203173D0 (en) Compounds
GB9203172D0 (en) Compounds
GB9203171D0 (en) Compounds
GB9203170D0 (en) Compounds
GB9202991D0 (en) Compounds
GB9210661D0 (en) Compounds
GB9206093D0 (en) Compounds
GB9210660D0 (en) Compounds
GB9210633D0 (en) Compounds
GB9201819D0 (en) Compounds